The Parenteral Drug Association (PDA) is a leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community.
SeerPharma Senior GMP Consultant Michelle Peake has been invited to speak at PDA Annex 1 Implementation: Inspection Ready Workshop 2025, 17 - 18 June 2025 in ...
The 2022 revision of the PIC/S Guide to GMP for Medicinal Products (PE 009-17) Annex 1 is expected to be adopted by the Therapeutic Goods Administration (TGA) in 2025 and Contamination Control Strategy (CCS) has emerged as a key new requirement. While CCS under Annex 1 is central for sterile drug manufacturers, it is also applicable for...
When manufacturing pharmaceuticals, the risk of contaminants impacting pharmaceutical safety, efficacy and purity is real.
Copyright © SeerPharma
